SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from PAVmed Inc. (PAVM) (CIK 0001624326) (PAVM) — Apr 20, 2020

PAVmed Inc. (PAVM) (CIK 0001624326)
Date: April 20, 2020 · CIK: 0001624326 · Accession: 0001493152-20-006775

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-235335

Date
December 3, 2019
Author
PAVMED
Form
CORRESP
Company
PAVmed Inc. (PAVM) (CIK 0001624326)

Letter

Re: PAVmed Inc.

PAVMED INC.

One Grand Central Place, Suite 4600

New York, New York 10165

April 20, 2020

Securities and Exchange Commission

Division of Corporation Finance

Washington, District of Columbia 20549

Registration Statement on Form S-3

Originally Filed December 3, 2019

File No. 333-235335

Ladies and Gentlemen:

Reference is made to our letter filed as correspondence via EDGAR on April 15, 2020, in which we requested the acceleration of the effectiveness of the above-referenced Registration Statement for April 17, 2020, at 4:30 p.m. Eastern Time, in accordance with Rule 461 of the Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective at such time and we hereby formally withdraw our request for acceleration of the effective date. We will advise you as soon as possible once we are ready to again request effectiveness of the Registration Statement.

Sincerely,
PAVMED
INC.

Show Raw Text
CORRESP
1
filename1.htm

PAVMED
INC.

One
Grand Central Place, Suite 4600

New
York, New York 10165

April
20, 2020

Securities
and Exchange Commission

Division
of Corporation Finance

Washington,
District of Columbia 20549

    Re:
    PAVmed
    Inc.

    Registration
    Statement on Form S-3

    Originally
    Filed December 3, 2019

    File
    No. 333-235335

Ladies
and Gentlemen:

Reference
is made to our letter filed as correspondence via EDGAR on April 15, 2020, in which we requested the acceleration of the effectiveness
of the above-referenced Registration Statement for April 17, 2020, at 4:30 p.m. Eastern Time, in accordance with Rule 461 of the
Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective at such
time and we hereby formally withdraw our request for acceleration of the effective date. We will advise you as soon as possible
once we are ready to again request effectiveness of the Registration Statement.

    Sincerely,

    PAVMED
    INC.

    By:
    /s/
    Dennis M. McGrath

    Name:
    Dennis
    M. McGrath

    Title:
    President
    and Chief Financial Officer